초록 ▼

A method of providing halotherapy to the upper portion of the lower respiratory tract includes the steps of operating a dispenser and inhaling. The dispenser contains a dry sodium chloride powder. The user operates the dispenser to release a dosage of the powder for inhalation when the dispenser is

A method of providing halotherapy to the upper portion of the lower respiratory tract includes the steps of operating a dispenser and inhaling. The dispenser contains a dry sodium chloride powder. The user operates the dispenser to release a dosage of the powder for inhalation when the dispenser is aimed into the user's mouth. The user then inhales the dosage of powder through the mouth. Because the powder has a particle size range enabling the powder to target the upper portion of the lower respiratory tract without entering the user's lungs, the dosage of the dry powder provides a concentration at the upper portion sufficient to provide effective halotherapy. The preferred particle size range is from about 5 microns to about 20 microns. The preferred dosage is about 3 milligrams of powder.

대표청구항 ▼

[ What is claimed is:] [1.] A method of providing halotherapy to an upper portion of a lower respiratory tract of a user, said method comprising the steps of:a) operating a dispenser containing dry sodium chloride powder, said dispenser releasing a dosage of said powder for inhalation when aimed int

[ What is claimed is:] [1.] A method of providing halotherapy to an upper portion of a lower respiratory tract of a user, said method comprising the steps of:a) operating a dispenser containing dry sodium chloride powder, said dispenser releasing a dosage of said powder for inhalation when aimed into a user's mouth;b) directing said dosage of said powder, said powder having a particle size range from about 5 microns to about 20 microns, said powder particle size range being not less than 5 microns, said powder particle size range enabling said powder to target the upper portion of the lower respiratory tract of the user without entering the user's lungs when inhaled by the user, said dosage of said dry powder providing a concentration at the upper portion of the lower respiratory tract of the user sufficient to provide effective halotherapy.